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Clinical Trial
SES Superior to BMS in Diabetics
The SCORPIUS study is the largest multicenter, randomized study in diabeticpatients comparing sirolimus-eluting stents (SES) versus bare-metal stents
(BMS). Two hundred patients with diabetes were randomized to SES or BMS with
angiographic follow-up at 8 months. Both in-segment restenosis (50%) and target
lesion revascularization (TLR) were 4 times more likely to occur with BMS than SES.
The SES is safe and effectively reduces clinical and angiographic restenosis in diabetics.
See page 1627. See figure.
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Interventional Cardiology
Plaque Necrotic Core Volume Predicts Risk of Distal Embolization
In this issue, two articles examine the relationship between plaque composition,assessed by Virtual Histology intravascular ultrasound (VH-IVUS), and the risk of
distal embolization. In the first study, 71 patients with ST-segment elevation myocar-
dial infarction undergoing primary percutaneous coronary intervention (PCI) were
evaluated for ST-segment re-elevation as a marker of distal embolization. The necrotic
core volume in the culprit lesion was themajor predictor of distal embolization. In the
second study, 44 patients with angina undergoing PCI were evaluated for high-
intensity transient signals using a Doppler guidewire in the distal vessel. Similarly, the
necrotic core size by VH-IVUS before PCI was an independent predictor of distal
embolization. An accompanying editorial stresses that these findings may help us to
understand distal embolization but offer little information on how to prevent it.
See pages 1635, 1641, and 1647. See figure.
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Coronary Artery Disease
Statins Protective for Vascular Surgery
Feringa and colleagues tested the hypothesis that statins are cardioprotective inpatients undergoing vascular surgery. In a prospective study of 359 patients, statin
dose and cholesterol levels were recorded before surgery. Inmultivariate analysis, lower
low-density lipoprotein (LDL) cholesterol correlated with less frequent myocardial
ischemia, troponin T release, 30-day cardiac events, and late cardiac events. Higher
statin doses (expressed as percentage ofmaximumrecommended therapeutic dose) also
correlated with these outcomes, even after adjusting for LDL cholesterol. These results
suggest that statins are cardioprotective for patients undergoingmajor vascular surgery,
both directly by lowering LDL cholesterol and possibly through pleiotropic effects.
See page 1649. See figure.
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Heart Failure
Intravenous Iron Improves EF, Symptoms, and BNP
Forty subjects with ejection fraction 35%, hemoglobin 12.5 g/dl, and ironsaturation20%were randomized to 5 weekly infusions of iron sucrose complex
(ISC) or placebo. Six months later, those who had received ISC had higher ejection
fractions and lower brain natriuretic peptide (BNP) levels. They also had a higherNew
York Heart Association functional class, fewer hospitalizations, and improved creati-
nine clearance. This study suggests that treating iron deficiency with ISC can substan-
tially improve a patient’s symptoms, as well as several markers of disease severity.
See page 1657. See figure.
